Trial Profile
The effect of tolvaptan in heart failure patients with loop diuretic resistance.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Sep 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 29 Aug 2016 Status changed from recruiting to discontinued.
- 04 Apr 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan record.
- 04 Mar 2015 New trial record